CVS Pharmacy - additional testing funding

The contract involves additional funding allocated to CVS Pharmacy to support expanded testing efforts, as initiated by the Centers for Disease Control and Prevention (CDC). This forecasted opportunity, posted in March 2026, indicates a focus on enhancing public health testing capabilities through a partnership with CVS Pharmacy, though specific solicitation details and set-aside classifications are not provided. The contract aims to bolster disease monitoring and control measures, reflecting the CDC’s ongoing commitment to public health infrastructure improvement. Key contacts for this contract include Holly Nickle, serving as the program point of contact, and an unnamed contracting officer, both reachable via the same CDC email address. While the precise location for contract performance and additional logistical details remain unspecified, the overall intent is clear: to secure additional resources for testing through CVS, facilitating broader accessibility and efficiency in health services. This initiative aligns with CDC’s strategic priorities to expand testing capacity and improve response to public health needs.